Table 4. The baseline demographic and clinical characteristics of the 71 CAD patients according to the number of diseased vessels.
| One-vessel | Two-vessel | Three-vessel | P value | |
|---|---|---|---|---|
| (n = 12) | (n = 30) | (n = 29) | ||
| Age (years) | 71.6 ± 7.8 | 66.3 ± 9.4 | 70.8 ± 10.2 | 0.115 |
| Gender (male, %) | 9 (78.0) | 25 (83.3) | 23 (79.3) | 0.817 |
| Systolic blood pressure (mmHg) | 129 ± 15 | 130 ± 18 | 127 ± 21 | 0.806 |
| Heart rate (beats/min) | 67 ± 12 | 66 ± 8 | 70 ± 8 | 0.181 |
| Body mass index (kg/m2) | 23.5 ± 2.3 | 25.5 ± 4.7 | 24.4 ± 3.8 | 0.307 |
| TRACP-5b (mU/dL) | 356.0 (277.5, 407.3) | 295.0 (255.3, 449.3) | 430.0 (332.5, 612.0) | 0.018 |
| Osteoprotegerin (pmol/L) | 113.5 (83.7, 153.3) | 92.0 (64.7, 113.8) | 81.3 (56.7, 108.5) | 0.126 |
| High-sensitivity CRP (mg/L) | 0.36 (0.22, 6.01) | 0.69 (0.27, 0.96) | 1.11 (0.42, 3.27) | 0.201 |
| LDL cholesterol (mg/dL) | 104 ± 38 | 115 ± 33 | 115 ± 31 | 0.553 |
| HDL cholesterol (mg/dL) | 58 ± 12 | 51 ± 12 | 51 ± 12 | 0.075 |
| Calcium (mg/dL) | 9.1 ± 0.3 | 8.9 ± 1.3 | 8.8 ± 1.7 | 0.836 |
| eGFR (mL/min/1.73 m2) | 60.7 ± 12.6 | 65.5 ± 15.0 | 57.6 ± 17.5 | 0.166 |
| HbA1c (%) | 6.5 ± 0.6 | 6.1 ± 1.1 | 5.9 ± 0.5 | 0.066 |
| Gensini score | 35.5 (26.0, 46.3) | 37.5 (31.9, 53.4) | 71.0 (54.2, 102.5) | < 0.001 |
| LVEF (%) | 54.4 ± 13.6 | 56.6 ± 13.4 | 54.1 ± 14.4 | 0.767 |
| Hypertension (%) | 11 (91.7) | 28 (93.3) | 29 (100) | 0.329 |
| Diabetes (%) | 9 (75.0) | 14 (46.7) | 9 (31.0) | 0.035 |
| Active smoker (%) | 10 (83.3) | 25 (83.3) | 22 (75.9) | 0.739 |
The data are expressed as the mean ± SD or median (interquartile range). TRACP, tartrate-resistant acid phosphatase; differences in the number of diseased vessels among the three groups (one-vessel, two-vessel, three-vessel); CRP, C-reactive protein; LDL, low-density lipoprotein; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction